Back to Screener

Lantheus Holdings, Inc. - Common Stock (LNTH)

NASDAQ Mid Cap

Healthcare › In Vitro & In Vivo Diagnostic Substances

$93.06
Market Cap: $6.1B
Data as of Mar 31, 2026 (TTM)

Price History

Feb 9, 2026 — May 10, 2026

Investment Snapshot

  • Trading 113% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 5/9 — moderate financial health
  • Strong ROE of 24.6% with 19.7% net margin

Lantheus Holdings, Inc. - Common Stock (LNTH) is a Healthcare company operating in In Vitro & In Vivo Diagnostic Substances, listed on the NASDAQ , with a market capitalisation of $6.1 billion . Key value metrics: P/E ratio 20.3, P/B ratio 5.00, Piotroski F-Score 5 out of 9 (moderate financial health) .

Value Score

Key Metrics

P/E Ratio
20.34
5.00
EPS
$4.58
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Lantheus Holdings, Inc. - Common Stock — Fundamental Analysis Summary

Lantheus Holdings, Inc. - Common Stock (LNTH) is currently trading 113% above its Graham Number of $43.78, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 20.3x.

On financial health, LNTH shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 24.6% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.38.

StockPik's composite Value Score for LNTH is 76/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

LNTH reports a high gross margin of 61.6% (sector average: 40.1%) and a strong operating margin of 20.8%.

LNTH shows revenue growing at 1% year-over-year, with earnings declining at 25%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
EMBC $3.90 2.1 100
HCM $13.31 5.1 100
GMAB $27.06 1.8 100
CGEN $2.71 7.3 100
INVA $22.89 5.8 100
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
LNT
Next
LNZA